For people with autism, constipation, diarrhea, and abdominal pain often go along with the social struggles and repetitive behaviors that define the condition.
Boehringer Ingelheim advances weight loss drug to Phase III trials – Pharmaceutical Technology
Boehringer Ingelheim’s candidate stands out from other GLP-1 drugs in that it also targets the hormone glucagon. Image credit: Shutterstock/Michael Vi. Boehringer Ingelheim could soon